Qu Biologics Inc. Company

Qu Biologics develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer.
Technology: Others
Industry: PharmTech
Headquarters: Canada
Founded Date: 2007
Employees Number: 11-50
Investors Number: 4
Total Funding: €5.3M
Estimated Revenue: $10M to $50M
Last Funding Type: Grant

Visit Website
julie@qubiologics.com
https://twitter.com/qubiologics
Register and Claim Ownership